These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20355242)

  • 1. Hepatic osteodystrophy and liver cirrhosis.
    Goral V; Simsek M; Mete N
    World J Gastroenterol; 2010 Apr; 16(13):1639-43. PubMed ID: 20355242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.
    Monegal A; Navasa M; Guañabens N; Peris P; Pons F; Martinez de Osaba MJ; Rimola A; Rodés J; Muñoz-Gómez J
    Calcif Tissue Int; 1997 Feb; 60(2):148-54. PubMed ID: 9056162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone/insulin-like growth factor-1 axis, calciotropic hormones and bone mineral density in young patients with chronic viral hepatitis.
    Marek B; Kajdaniuk D; Niedziołka D; Borgiel-Marek H; Nowak M; Siemińska L; Ostrowska Z; Głogowska-Szeląg J; Piecha T; Otremba Ł; Holona K; Kazimierczak A; Wierzbicka-Chmiel J; Kos-Kudła B
    Endokrynol Pol; 2015; 66(1):22-9. PubMed ID: 25754278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures.
    Mitra D; Elvins DM; Collins AJ
    J Rheumatol; 1999 Oct; 26(10):2201-4. PubMed ID: 10529140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in bone mineral density and bone metabolism markers in premenopausal women with multiple sclerosis and the relationship to clinical variables.
    Terzi T; Terzi M; Tander B; Cantürk F; Onar M
    J Clin Neurosci; 2010 Oct; 17(10):1260-4. PubMed ID: 20619660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease.
    García-Valdecasas-Campelo E; González-Reimers E; Santolaria-Fernández F; De la Vega-Prieto MJ; Milena-Abril A; Sánchez-Pérez MJ; Martínez-Riera A; Gómez-Rodríguez Mde L
    Alcohol Alcohol; 2006; 41(3):261-6. PubMed ID: 16476762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease.
    Duarte MP; Farias ML; Coelho HS; Mendonça LM; Stabnov LM; do Carmo d Oliveira M; Lamy RA; Oliveira DS
    J Gastroenterol Hepatol; 2001 Sep; 16(9):1022-7. PubMed ID: 11595067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density in prepubertal children with beta-thalassemia: correlation with growth and hormonal data.
    Soliman AT; El Banna N; Abdel Fattah M; ElZalabani MM; Ansari BM
    Metabolism; 1998 May; 47(5):541-8. PubMed ID: 9591744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between serum leptin levels and bone mineral density and bone metabolic markers in patients on hemodialysis.
    Ahmadi F; Salari S; Maziar S; Esfahanian F; Khazaeipour Z; Ranjbarnovin N
    Saudi J Kidney Dis Transpl; 2013 Jan; 24(1):41-7. PubMed ID: 23354190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa.
    Grinspoon S; Baum H; Lee K; Anderson E; Herzog D; Klibanski A
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3864-70. PubMed ID: 8923830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic osteodystrophy is common in patients with noncholestatic liver disease.
    Choudhary NS; Tomar M; Chawla YK; Bhadada SK; Khandelwal N; Dhiman RK; Duseja A; Bhansali A
    Dig Dis Sci; 2011 Nov; 56(11):3323-7. PubMed ID: 21573732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
    Jehle PM; Jehle DR; Mohan S; Böhm BO
    J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis.
    Gallego-Rojo FJ; Gonzalez-Calvin JL; Muñoz-Torres M; Mundi JL; Fernandez-Perez R; Rodrigo-Moreno D
    Hepatology; 1998 Sep; 28(3):695-9. PubMed ID: 9731561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study of osteopenia in liver cirrhosis by dual energy X-ray absorptiometry (DXA)].
    Nakano A; Kanda T; Miyamoto T; Ishigami Y; Sato T; Shimizu Y
    Nihon Shokakibyo Gakkai Zasshi; 1993 Aug; 90(8):1689-94. PubMed ID: 8361060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic osteodystrophy in cirrhosis due to alcohol-related liver disease.
    Pereira F; Azevedo R; Linhares M; Pinto J; Leitão C; Caldeira A; Tristan J; Pereira E; Sousa R; Banhudo A
    Rev Esp Enferm Dig; 2021 Aug; 113(8):563-569. PubMed ID: 33267594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairment of bone mass development in children with chronic cholestatic liver disease.
    de Albuquerque Taveira AT; Fernandes MI; Galvão LC; Sawamura R; de Mello Vieira E; de Paula FJ
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):518-23. PubMed ID: 17371469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
    Kemink SA; Hermus AR; Swinkels LM; Lutterman JA; Smals AG
    J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.
    Colao A; Di Somma C; Pivonello R; Loche S; Aimaretti G; Cerbone G; Faggiano A; Corneli G; Ghigo E; Lombardi G
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.